← Back to Search

Aromatase Inhibitor

Letrozole for Breast Cancer

Phase < 1
Waitlist Available
Led By Andrew Brenner, MD, PhD
Research Sponsored by The University of Texas Health Science Center at San Antonio
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Study Summary

This trial will assess the impact of dietary omega 3 free fatty acids and/or letrozole on obese, postmenopausal breast cancer patients.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in levels of aromatase target gene.
Change in serum levels of PGE2 (prostaglandin E2).

Trial Design

3Treatment groups
Active Control
Group I: LetrozoleActive Control1 Intervention
Letrozole 2.5 mg by mouth daily for 30 days.
Group II: Fish OilActive Control1 Intervention
Fish oil 2700 mg by mouth daily for 30 days.
Group III: Letrozole and Fish OilActive Control2 Interventions
Letrozole 2.5 mg and Fish oil 2700 mg by mouth daily for 30 days.

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center at San AntonioLead Sponsor
450 Previous Clinical Trials
87,237 Total Patients Enrolled
14 Trials studying Breast Cancer
1,516 Patients Enrolled for Breast Cancer
Andrew Brenner, MD, PhDPrincipal InvestigatorPrincipal Investigator
1 Previous Clinical Trials
26 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has Letrozole been studied in any other research studies?

"Presently, 153 trials are underway to explore the efficacy of Letrozole. Of those studies, 39 are in their final stage and based primarily in San Francisco. There are also an additional 10967 medical centres conducting research on this particular treatment."

Answered by AI

What medical indication is Letrozole commonly prescribed for?

"Letrozole is a beneficial medication for treating breast cancer, irregular menstrual cycles, and tamoxifen resistance."

Answered by AI

What is the scale of participation in this experiment?

"Affirmative, clinicaltrials.gov shows this trial is presently enrolling individuals. It was initially advertised on April 1st 2016 and refreshed most recently on August 25th 2022, with a goal of obtaining 60 volunteers at one site."

Answered by AI

Are volunteers able to join this clinical experiment presently?

"Affirmative. According to the clinicaltrials.gov database, this research project is actively seeking participants since its initial posting on April 1st 2016 and most recent update on August 25th 2022. Specifically, 60 individuals are needed across one location."

Answered by AI
~3 spots leftby Mar 2025